FDA Approved: ENTECAVIR — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for Entacavir (ENTECAVIR) filed by NorthStar RxLLC under ANDA 206872.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Entacavir (Entacavir)

Snippet

SUPPL AP for ENTECAVIR (ENTECAVIR)